Parkinson Disease 13

Known as: PARK13 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2016
01220072016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Mutations in High temperature requirement A2 (HtrA2), also designated PARK13, which lead to the loss of its protease activity… (More)
Is this relevant?
2017
2017
Background. HTRA2 has already been nominated as PARK13 which may cause Parkinson's disease, though there are still discrepancies… (More)
  • table 1
  • table 2
  • table 4
  • table 5
Is this relevant?
2016
2016
Although mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common cause of genetic Parkinson's disease… (More)
Is this relevant?
2014
2014
Mutations in HTRA2/Omi/PARK13 have been implicated in Parkinson disease (PD). PARK13 is a neuroprotective serine protease… (More)
Is this relevant?
2014
2014
Parkinson's disease (PD) is a progressive and irreversible neurodegenerative disorder coupled to selective degeneration of… (More)
Is this relevant?
2011
2011
High-profile studies have provided conflicting results regarding the involvement of the Omi/HtrA2 gene in Parkinson's disease (PD… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
In mice, targeted deletion of the serine protease HtrA2 (also known as Omi) causes mitochondrial dysfunction leading to a… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2007
Review
2007
Studies of familial forms of Parkinson's disease (PD) have identified a growing number of genes that derive from the loci given… (More)
Is this relevant?